Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex for IONM in Thyroid Surgery
NCT03634956Unknown
- Sponsor
- Lütfiye Nuri Burat State Hospital
- Start
- Aug 2018
- Primary completion
- Feb 2019
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of Sugammadex in neuromuscular blockade (NMB) (2 arms), sponsored by Lütfiye Nuri Burat State Hospital. Primary endpoint: Vocal cord paralysis. Status: unknown.
02
Drugs
Sugammadex
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT03634956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03634956.